Trial Profile
A Pilot Study on Transplantation Therapy Using Autologous Bone Marrow Mononuclear Cells and Umbilical Cord Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Cellonis Biotechnologies
- 02 May 2014 New trial record